Otobe S, Sugaya M, Nakajima R, Oka T, Takahashi N, Kabasawa M, Miyagaki T, Asano Y, Sato S: Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome. J Dermatol. 45(4): 468-471 2018
Hoashi T, Asahara M, Shirakawa N, Mayumi N, Nakayama K, Omori I, Inokuchi K, Sugaya M, Funasaka Y, Saeki H: Case of primary cutaneous anaplastic large cell lymphoma misdiagnosed as squamous cell carcinoma by pseudocarcinomatous hyperplasia. J Dermatol. 45(6): e163-e164 2018
Sakamoto M, Miyagaki T, Kamijo H, Oka T, Takahashi N, Suga H, Yoshizaki A, Asano Y, Sugaya M, Sato S: Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome. J Dermatol 45(1):95-99 2018
Nakajima R, Miyagaki T, Kamijo H, Oka T, Shishido-Takahashi N, Suga H, Sugaya M, Sato S: Decreased progranulin expression in Mycosis fungoides: a possible association with the high frequency of skin infections. Eur J Dermatol 28(6): 790-794 2018
Kamijo H, Miyagaki T, Shishido-Takahashi N, Nakajima R, Oka T, Suga H, Sugaya M, Sato S: Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma. Blood 132(18): 1922-1935 2018
Suzuki H, Sugaya M, Nakajima R, Oka T, Takahashi N, Nakao M, Miyagaki T, Asano Y, Sato S: Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T-cell lymphoma. J Dermatol 45(12): 1440-1443 2018
Senda N, Miyagaki T, Kamijo H, Nakajima R, Oka T, Takahashi N, Suga H, Yoshizaki A, Asano Y, Sugaya M, Sato S: Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma. Eur J Dermatol 28(5): 621-627 2018
Senda N, Miyagaki T, Oka T, Itoigawa A, Kikuchi K, Kobayashi T, Nakamura F, Kurokawa M, Sugaya M, Sato S: Case of extranodal natural killer/T-cell lymphoma, nasal type, accompanied by Epstein-Barr virus-positive nasopharyngeal carcinoma. J Dermatol 2018
Hau CS, Shimizu T, Tada Y, Kamata M, Takeoka S, Shibata S, Mitsui A, Asano Y, Sugaya M, Kadono T, Sato S, Watanabe S: The vitamin D3 analog, maxacalcitol, reduces psoriasiform skin inflammation by inducing regulatory T cells and downregulating IL-23 and IL-17 production. J Dermatol Sci 92(2): 117-126 2018
Yamashita T, Asano Y, Saigusa R, Taniguchi T, Nakamura K, Miura S, Toyama T, Takahashi T, Ichimura Y, Hirabayashi M, Yoshizaki A, Miyagaki T, Sugaya M, Sato S: Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis. J Dermatol Sci 93(1): 24-32 2018
Oka T, Miyagaki T, Takahashi N, Nakajima R, Kamijo H, Suga H, Asano Y, Sugaya M, Sato S: Serum Soluble CD48 Levels as a Prognostic Marker in Mycosis Fungoides and Sézary Syndrome J Inv Dermatol 138(10): 2286-2288 2018
Akatsuka T, Miyagaki T, Nakajima R, Kamijo H, Oka T, Takahashi N, Suga H, Yoshizaki A, Asano Y, Sugaya M, Sato S: Decreased IL-10-producing regulatory B cells in patients with advanced mycosis fungoides Eur J Dermatol 28(3): 314-319 2018
Nakajima R, Miyagaki T, Morimura S, Fukasawa T, Oka T, Yoshizaki A, Sugaya M, Sato S: Exacerbated Immune Complex-Mediated Vascular Injury in Mice with Heterozygous Deficiency of Aryl Hydrocarbon Receptor through Upregulation of Fcγ Receptor III Expression on Macrophages. J Inv Dermatol 138(10): 2195-2204 2018
Kawaguchi M, Oka T, Sugaya M, Suga H, Kimura T, Morimura S, Fujita H, Sato S IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation. J Dermatol Sci 90(1): 35-45 2018
Otobe S, Sugaya M, Taniguchi T, Miyagaki T, Iozumi K, Sato S: Adult T-cell leukemia/lymphoma with subungual hematomas in all fingers and toes as the first manifestation. J Dermatol 45(3): 378-379 2018
Hirabayashi M, Asano Y, Yamashita T, Miura S, Nakamura K, Taniguchi T, Saigusa R, Takahashi T, Ichimura Y, Miyagawa T, Yoshizaki A, Miyagaki T, Sugaya M, Sato S: Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosis. J Dermatol 45(2): 182-188 2018
